Differential distribution of free and bound glutathione and cyst(e)ine in human blood

Biochemical Pharmacology

Volumn 52, Issue 3, 1996, Pages 401-406

  Mills, Betty Jane ^a,b   Lang, Calvin A ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

cyst(e)ine; erythrocytes; free and bound; glutathione; human blood; plasma

Indexed keywords

CYSTEINE; CYSTINE; GLUTATHIONE;

ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; NORMAL HUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; TISSUE DISTRIBUTION; TOXICOLOGY;

EID: 0030576641     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00241-9     Document Type: Article

References (60)

1. 1. Kosower NS and Kosower EM, The glutathione status of cells. Int Rev Cytol 54: 109-160, 1978.
2. 2. Kosower EM and Kosower NS, Manifestations of changes in the G-SH-G-S-S-G status of biological systems. In: Glutathione (Eds. Flohé L, Benöhr HCh, Sies H, Waller HD and Wendel A), pp. 287-297. Academic Press, New York, 1974.
3. 3. Richte JP Jr and Lang CA, The determination of glutathione, cyst(e)ine and other thiols and disulfides in biological samples using high-performance liquid chromatography and dual electrochemical detection. Anal Biochem 163: 9-15, 1986.
4. 4. Lang CA, Naryshkin S, Schneider DL, Mills BJ and Lindeman RD, Low blood glutathione levels in healthy aging adults. J Lab Clin Med 120: 720-725, 1992.
5. 5. Mills BJ, Richie JP Jr and Lang CA, Glutathione disulfide variability in normal human blood. Anal Biochem 222: 95-101, 1994.
6. 6. Stein WH and Moore S, The free amino acids of human blood plasma. J Biol Chem 211: 915-926, 1954.
7. 7. Eagle H, Oyama VI and Piez KA, The reversible binding of half-cystine residues to serum protein, and its bearing on the cystine requirement of cultured mammalian cells. J Biol Chem 235: 1719-1726, 1960.
8. 8. Isaacs J and Binkley F, Glutathione dependent control of protein disulfide-sulfhydryl content by subcellular fractions of hepatic tissue. Biochim Biophys Acta 497: 192-204, 1977.
9. 9. DeLucia AJ, Mustafa MG, Hussain MZ and Cross CE, Ozone interaction with rodent lung. III. Oxidation of reduced glutathione and formation of mixed disulfides between protein and nonprotein sulfhydryls. J Clin Invest 55: 794-802, 1975.
10. 10. Keeling PL, Smith LL and Aldridge WN, The formation of mixed disulfides in rat lung following paraquat administration. Biochim Biophys Acta 716: 249-257, 1982.
11. 11. Brigelius R, Lenzen R and Sies H, Increase in hepatic mixed disulfides and glutathione levels elicited by paraquat. Biochem Pharmacol 31: 1637-1641, 1982.
12. 12. Kosower NS and Kosower EM, Functional aspects of glutathione disulfide and hidden forms of glutathione. In: Glutathione Metabolism and Function (Eds. Arias IM and Jakoby WB), pp. 159-174. Raven Press, New York, 1976.
13. 13. Harrap KR, Jackson RC, Riches PG, Smith CA and Hill BT, The occurrence of protein-bound mixed disulfides in rat tissues. Biochim Biophys Acta 310: 104-110, 1973.
14. 14. Brigelius R, Muckel C, Akerboom TPM and Sies H, Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem Pharmacol 32: 2529-2534, 1983.
15. 15. Dupuy D and Szabo S, Measurement of tissue sulfhydryls and disulfides in tissue protein and nonprotein fractions by high performance liquid chromatography using electrochemical detection. J Liq Chromatog 10: 107-119, 1987.
16. 16. Gelatt KN, Bruss M, DeCostanza SM, Noonan NE, Das ND and Wolf ED, Reduced, oxidized, and protein-bound glutathione concentrations in normal and cataractous lenses in the dog. Am J Vet Res 43: 1215-1217, 1982.
17. 17. Benard O and Balasubramanian KA, Effect of oxidant exposure on thiol status in the intestinal mucosa. Biochem Pharmacol 45: 2011-2015, 1993.
18. 18. Modig H, Cellular mixed disulfides between thiols and proteins, and their possible implication for radiation protection. Biochem Pharmacol 17: 177-186, 1968.
19. 19. Harding JJ, Free and bound glutathione in normal and cataractous human lenses. Biochem J 117: 957-960, 1970.
20. 20. Reddy VN and Han RF, Protein-bound glutathione in mammalian lenses and in galactose cataract. Doc Ophthalmol Proc Series 8: 153-160, 1976.
21. 21. Wu XB, Brune B, von Appen F and Ullrich V, Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch Biochem Biophys 294: 75-82, 1992.
22. 22. Andersson A, Isaksson A, Brattström L and Hultberg B, Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 39: 1590-1597, 1993.
23. 23. Mansoor MA, Svardal AM and Ueland PM, Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200: 218-229, 1992.
24. 24. Witschi A, Reddy S, Stofer B and Lauterberg BH, The systemic availability of oral glutathione. Eur J Clin Pharmacol 43: 667-669, 1992.
25. 25. Porta P, Aebi S, Summer K and Lauterberg BH, L-2-Oxothia-zolidine-4-carboxylic acid (OTC), a cysteine prodrug: Pharmacokinetics and effects on thiols in plasma and lymphocytes of man. J Pharmacol Exp Ther 257: 331-334, 1991.
26. 26. Svardal AM, Mansoor MA and Ueland PM, Determination of reduced, oxidized and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 184: 338-346, 1990.
27. 27. Johansson M and Lenngren S, Determination of cysteine, glutathione and N-acetylcysteine in plasma by ion-pair reversed-phase liquid chromatography and post-column derivatization. J Chromatogr 432: 65-74, 1988.
28. 28. Märtenssen J, The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations. Metabolism 35: 118-121, 1986.
29. 29. Fiskerstrand T, Refsum H, Kvalheim G and Ueland PM, Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 39: 263-271, 1993.
30. 30. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T and Kita T, Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 79: 139-146, 1989.
31. 31. Wiley VC, Dudman NPB and Wilcken DEL, Interrelations between plasma free and protein-bound homocysteine in homocystinuria. Metabolism 37: 191-195, 1988.
32. 32. Smolin LN, Laidlaw SA and Kopple JD, Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis. Am J Clin Nutr 45: 737-743, 1987.
33. 33. Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RGB and Rudman D, Plasma cysteine, cystine and glutathione in cirrhosis. Gastroenterology 87: 770-774, 1984.
34. 34. Malloy MH, Rassin DK and Gaull GE, A method for measurement of free and bound plasma cyst(e)ine. Anal Biochem 113: 407-415, 1981.
35. 35. Brown BA, Routine hematology procedure. In: Hematology: Principles and Procedures, 6th Edn, Chap. 3, pp. 83-102. Lea & Febiger, Philadelphia, 1993.
36. 36. Snedecor GW and Cochran WG, Statistical Methods, 7th Edn. Iowa State University Press, Ames, IA, 1980.
37. 37. Hagenfeldt L, Arvidsson A and Larsson A, Glutathione and γ-glutamylcysteine in whole blood, plasma and erythrocytes. Clin Chim Acta 85: 167-173, 1978.
38. 38. Ellman GL and Lysko H, Disulfide and sulfhydryl compounds in TCA extracts of human blood and plasma. J Lab Clin Med 70: 518-527, 1967.
39. 39. Johnson CA and Bergeim O, The distribution of free amino acids between erythrocytes and plasma in man. J Biol Chem 188: 833-838, 1951.
40. 40. Levy HL and Barkin E, Comparison of amino acid concentrations between plasma and erythrocytes. Studies in normal human subjects and those with metabolic disorders. J Lab Clin Med 78: 517-523, 1971.
41. 41. Newton GL, Dorian R and Fahey RC, Analysis of biological thiols: Derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem 114: 383-387, 1981.
42. 42. Hagenfeldt L and Arvidsson A, The distribution of amino acids between plasma and erythrocytes. Clin Chim Acta 100: 133-141, 1980.
43. 43. Schaefer A, Piquard F and Haberey P, The effects of changes in plasma amino acid concentrations on erythrocyte amino acid content. Clin Biochem 23: 237-240, 1990.
44. 44. Haest CWM, Kamp D and Deuticke B, Formation of disulfide bonds between glutathione and membrane SH groups in human erythrocytes. Biochim Biophys Acta 557: 363-371, 1979.
45. 45. Cecil R and McPhee JR, The sulfur chemistry of proteins. In: Advances in Protein Chemistry (Eds. Anfinsen CB, Anson ML, Bailey K and Edsell JT), Vol. XIV, pp. 255-389. Academic Press, New York, 1959.
46. 46. Allen DW and Jandl JH, Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols in oxidant drug action. J Clin Invest 40: 454-475, 1961.
47. 47. Huisman THJ and Dozy AM, Studies on the heterogeneity of hemoglobin. V. The binding of hemoglobin with oxidized glutathione. J Lab Clin Med 60: 302-309, 1962.
48. 48. Garel M-C, Domenget C, Caburi-Martin J, Prehu C, Galacteros F and Beuzard Y, Covalent binding of glutathione to hemoglobin. J Biol Chem 261: 14704-14709, 1986.
49. 49. Srivastava SK and Beutler E, Glutathione metabolism of the erythrocyte. The enzymic cleavage of glutathione-hemoglobin preparations by glutathione reductase. Biochem J 119: 353-357, 1970.
50. 50. Anderson ME and Meister A, Dynamic state of glutathione in blood plasma. J Biol Chem 255: 9530-9533, 1980.
51. 51. Wendel A and Cikryt P, The level and half-life of glutathione in human plasma. FEBS Lett 120: 209-211, 1980.
52. 52. Beutler E and Gelbart T, Plasma glutathione in health and in patients with malignant diseases. J Lab Clin Med 105: 581-584, 1985.
53. 53. Lash HL and Jones DP, Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch Biochem Biophys 240: 583-592, 1985.
54. 54. Curello S, Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress. Clin Chem 33: 1448-1449, 1987.
55. 55. Andersson A, Lindren A and Hultberg B, Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem 41: 361-366, 1995.
56. 56. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR and Loscalzo J, Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89: 7674-7677, 1992.
57. 57. Smolin LA and Benevenga NJ, Methionine, homocyst(e)ine, cyst(e)ine - Metabolic relationships. In: Absorption and Utilization of Amino Acids (Ed. Friedman M), Vol. I, Chap. 8, pp. 157-187. CRC Press, Boca Raton, FL, 1989.
58. 58. Cotgreave IA, Weis M, Atzori L and Moldéus P, Glutathione and protein function. In: Glutathione: Metabolism and Physiological Functions (Ed. Viña J), Chap. 2, pp. 155-175. CRC Press, Boca Raton, FL, 1990.
59. 59. Mansoor MA, Bergmark C, Svardal MA, Lonning PE and Ueland PM, Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 15: 232-240, 1995.
60. 60. Hultberg B, Andersson A, Masson P, Larson M and Tunek A, Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest 54: 417-422, 1994.